These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15311028

  • 1. Clinical experiences with desmopressin for long-term treatment of nocturia.
    Lose G, Mattiasson A, Walter S, Lalos O, van Kerrebroeck P, Abrams P, Freeman R.
    J Urol; 2004 Sep; 172(3):1021-5. PubMed ID: 15311028
    [Abstract] [Full Text] [Related]

  • 2. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP.
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK, Dmochowski RR, Reddy J, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [Abstract] [Full Text] [Related]

  • 4. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study.
    Bae JH, Oh MM, Shim KS, Cheon J, Lee JG, Kim JJ, Moon DG.
    J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP, Herschorn S, Albei CD, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [Abstract] [Full Text] [Related]

  • 6. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [Abstract] [Full Text] [Related]

  • 7. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP.
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM, Riis A, Nørgaard JP, Djurhuus JC.
    BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
    [Abstract] [Full Text] [Related]

  • 9. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR, Lin WY, Wu CF, Shee JJ, Huang YC, Chen CS.
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [Abstract] [Full Text] [Related]

  • 10. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
    Lottmann H, Baydala L, Eggert P, Klein BM, Evans J, Norgaard JP.
    Int J Clin Pract; 2009 Jan; 63(1):35-45. PubMed ID: 19125991
    [Abstract] [Full Text] [Related]

  • 11. Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome.
    Hashim H, Malmberg L, Graugaard-Jensen C, Abrams P.
    Neurourol Urodyn; 2009 Jan; 28(1):40-6. PubMed ID: 18726947
    [Abstract] [Full Text] [Related]

  • 12. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
    Rembratt A, Riis A, Norgaard JP.
    Neurourol Urodyn; 2006 Jan; 25(2):105-9. PubMed ID: 16304673
    [Abstract] [Full Text] [Related]

  • 13. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG, Lavery HJ, Wu DL.
    Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria].
    Terada N, Arakaki R, Okada Y, Kitahara M, Kaneko Y, Omori K, Nishimura K.
    Hinyokika Kiyo; 2005 Mar; 51(3):151-4. PubMed ID: 15852666
    [Abstract] [Full Text] [Related]

  • 15. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
    Wolfish NM, Barkin J, Gorodzinsky F, Schwarz R.
    Scand J Urol Nephrol; 2003 Mar; 37(1):22-7. PubMed ID: 12745738
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 17. Desmopressin: in adults with nocturia.
    Cvetković RS, Plosker GL.
    Drugs; 2005 Jun; 65(1):99-107; discussion 108-9. PubMed ID: 15610055
    [Abstract] [Full Text] [Related]

  • 18. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria.
    Chang YL, Lin AT, Chen KK.
    J Urol; 2007 Jun; 177(6):2227-9; discussion 2230. PubMed ID: 17509326
    [Abstract] [Full Text] [Related]

  • 19. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns.
    Rembratt A, Norgaard JP, Andersson KE.
    BJU Int; 2003 May; 91(7):642-6. PubMed ID: 12699476
    [Abstract] [Full Text] [Related]

  • 20. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP, Zinner NR, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.